Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Home infusion therapy ideally provides an ability to provide complex pharmaceutical products to patients. The advanced home infusion therapy offers patients a comprehensive and innovative source of health care in the comfort of their homes. The home infusion therapy mostly involves the intravenous or subcutaneous administration of drugs or biologics to an individual according to requirement. Besides, home infusion therapy is major having driving demand in Europe as the region has increasing population of diabetes, cardiovascular, and cancer patients. Also, technology advancement in home infusion therapy is expected to fuel the market growth in region.
The home infusion therapy market in Europe is driven by various factors like growing geriatric population, advancements in technology, rising prevalence of chronic disease. The Europe has large elderly population associated with different chronic diseases is expected to drive the demand for market during the estimated time period. Also, technological advancement in home infusion therapy products to enhance the safe outcomes for patient has accelerated the demand for market. Similarly, changing lifestyle and rising incidence of chronic diseases like cancer, cardiovascular diseases, copd, diabetes, has significantly contributed healthy growth in home infusion therapy market in Europe region. Besides, emerging medical sector, medical devices and healthcare facilities has boosted the demand for the market. The different home infusion therapy market features and its advantage to minimize the patient suffering and burden has provided ample of growth opportunity for market.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the Europe home infusion therapy market. In addition, complete analysis of changes on Europe home infusion therapy market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The Europe home infusion therapy market has positive growth due to COVID-19 as number of patient were having their therapies at homes which has ultimately boosted the growth of market.
The home infusion therapy market comprises of different market segment like product, application and country.
The Europe home infusion therapy market has different product including infusion pump, intravenous sets, IV cannulas, and needleless connectors. The infusion pump further includes sub segment like syringe infusion pump, ambulatory infusion pump, implantable infusion pump, insulin infusion pump and others. The infusion pump segment is likely to dominate in the market and maintain its dominance over the forecast period. The factor contributing in the market growth are these are majorly used to transmit fluid or medication according to precise requirement. It provide an ability for safe administration in controlled manner. The device also reduces error of medical cases which is expected to drive the market growth during the estimated time period. Also, the sub segment of infusion pump including syringe infusion pump followed by ambulatory infusion pump are expected to experience emerging demand in home infusion therapy market. Likewise, needleless connectors is contributing healthy growth in the market during the estimated time peirod.
The Europe home infusion therapy market finds its major application in anti-infective, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, endocrinology and others. Anti-Infective is anticipated to register major market share during the forecast period as the anti-infective are majorly used to administration of antibiotics, antivirals, antifungal medication in the patient. Also, these are mostly commonly prescribed home infusion therapies and can be managed safety in patient home. Likewise, chemotherapy is expected to witness increasing demand for market attributing to rising incidence of cancer in region. Thereby rising cases of cancer has increased the requirement for home infusion therapy thereby fuelling the demand for market.
Europe home infusion therapy market is studied for the following countries like Germany, U.K, France, Italy, Spain and Rest of Europe. Germany is expected to dominate in the Europe home infusion therapy market attributing to increasing incidence of chronic diseases and morality rates including diabetes, cancer, chronic obstructive pulmonary diseases (COPD) has significantly provided ample of growth opportunity for Europe home infusion therapy market. Besides, growing aging population associated with the different chronic diseases has led the demand for market. Furthermore, technological advancement in products and presence largest medical device industry in Germany has significantly contributed healthy growth in the market. Likewise, U.K is expected to hold second position in market during the forecast period owing to rising demand for chemotherapy to reduce the burden of cancer cases has fuel the growth of market.
The key players in home infusion therapy market are B. Braun Melsungen AG, Becton, Dickinson and Company (BD), Hospira, Inc, ICU Medical, Inc, Caesarea Medical Electronics Ltd, Baxter International Inc, JMS Co. Ltd, Smiths Medical, Eli Lilly and Company, Fresenius Kabi, Terumo Corporation and Cosmed among others.
April 2021: Medtronic had unveiled its extended infusion set, the first set that can be worn to deliver insulin for up to seven days in selected European countries. Infusion sets are tubing that provides insulin to the body form a pump and then usually need to be changed every few days. The extended infusion set doubles the times a set can be worn, it allows user to safely stay on insulin pump therapy with fewer interruption and insertion while providing improved convince for diabetes management routines.
April 2020: B.Braun Medical Inc had announced the US Food and Drug administration issued Emergency use authorization of B. Braun’s perfusor space syringe infusion pump, infusomat space volumetric infusion pump and outlook ES pump system for use in the tracheal delivery of continuous nebulized medication into nebulizer to treat patient of all ages with or suspended of having Coronavirus diseases.
The report analyses the Europe home infusion therapy market based on by product, application and country. The Europe home infusion therapy market has different product including infusion pump, intravenous sets, IV cannulas, and needleless connectors. The infusion pump further includes sub segment like syringe infusion pump, ambulatory infusion pump, implantable infusion pump, insulin infusion pump and others. The infusion pump segment is likely to dominate in the market and maintain its dominance over the forecast period. The Europe home infusion therapy market finds its major application in anti-infective, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, endocrinology and others. Anti-Infective is anticipated to register major market share during the forecast period. Europe home infusion therapy market is studied for the following countries like Germany, U.K, France, Italy, Spain and Rest of Europe.
Why to buy this report:
